Mesa Laboratories, Inc.
MLAB
$103.99
$4.204.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 29.07M | 32.29M | 26.00M | 29.99M | 30.11M |
| Total Receivables | 41.97M | 38.65M | 40.23M | 35.57M | 39.06M |
| Inventory | 25.37M | 28.12M | 29.74M | 31.77M | 32.68M |
| Prepaid Expenses | 2.36M | 3.25M | 3.67M | 3.93M | 2.93M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.91M | 8.53M | 8.33M | 5.44M | 4.58M |
| Total Current Assets | 102.69M | 110.85M | 107.98M | 106.69M | 109.35M |
|
|
|||||
| Total Current Assets | 102.69M | 110.85M | 107.98M | 106.69M | 109.35M |
| Net Property, Plant & Equipment | 48.72M | 31.60M | 32.07M | 31.40M | 41.44M |
| Long-term Investments | 181.76M | 177.15M | 183.75M | 179.72M | 180.10M |
| Goodwill | 181.76M | 177.15M | 183.75M | 179.72M | 180.10M |
| Total Other Intangibles | 96.88M | 98.18M | 108.82M | 109.46M | 113.75M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.31M | 19.37M | 21.47M | 13.09M | 2.16M |
| Total Assets | 433.35M | 437.15M | 454.10M | 440.36M | 446.80M |
|
|
|||||
| Total Accounts Payable | 5.75M | 4.09M | 5.99M | 5.66M | 6.04M |
| Total Accrued Expenses | 27.46M | 21.84M | 17.29M | 16.93M | 18.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 104.57M | 104.45M | 104.27M | 6.69M | 2.99M |
| Total Finance Division Other Current Liabilities | 26.18M | 25.50M | 25.69M | 25.59M | 17.09M |
| Total Other Current Liabilities | 26.18M | 25.50M | 25.69M | 25.59M | 17.09M |
| Total Current Liabilities | 163.96M | 155.88M | 153.23M | 54.87M | 44.31M |
|
|
|||||
| Total Current Liabilities | 163.96M | 155.88M | 153.23M | 54.87M | 44.31M |
| Long-Term Debt | 76.90M | 94.80M | 104.20M | 208.50M | 221.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.38M | 12.36M | 14.39M | 6.30M | 6.61M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.27M | 18.89M | 20.83M | 19.97M | 28.78M |
| Total Liabilities | 273.52M | 281.93M | 292.65M | 289.63M | 301.40M |
|
|
|||||
| Common Stock & APIC | 358.54M | 352.79M | 349.53M | 346.00M | 343.64M |
| Retained Earnings | -188.94M | -180.95M | -178.41M | -180.97M | -183.49M |
| Treasury Stock & Other | -9.78M | -16.62M | -9.67M | -14.30M | -14.76M |
| Total Common Equity | 159.83M | 155.21M | 161.45M | 150.73M | 145.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 159.83M | 155.21M | 161.45M | 150.73M | 145.39M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 159.83M | 155.21M | 161.45M | 150.73M | 145.39M |
|
|
|||||